newsfilter
← Latest News
GlobeNewswire·

T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity

Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- T2